News
Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...
2don MSN
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...
1d
News-Medical.Net on MSNIL-12 cytokine factory demonstrates success in targeting hard-to-treat cancersA team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, ...
12h
News-Medical.Net on MSNNew quinoline-based antiviral shows strong promise against SARS-CoV-2Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).
Doctor reveals the best alternatives to surgery for chronic joint pain; shares 8 game-changing treatments, therapies, diet plan and lifestyle modification tips.
A systematic review published in Discover Oncology explores the anticancer efficacy of medicinal plant extracts in treating Oral Squamous Cell Carcinoma (O | Plants And Animals ...
Patients with chronic lymphocytic leukemia (CLL) who experience Richter transformation have a poor prognosis, but ibrutinib ...
These therapies, such as monoclonal antibodies and cytokine inhibitors, help reduce inflammation at the molecular level. For example, IL-1 and TNF-alpha inhibitors are being used to target ...
Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.
WITH an impressive attendance of 20,522 participants from 131 countries, the European Congress of Radiology (ECR) 2025 was an ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results